204 related articles for article (PubMed ID: 15368654)
1. Characteristics of COX2 inhibitors questioned.
Petit-Zeman S
Nat Rev Drug Discov; 2004 Sep; 3(9):726-7. PubMed ID: 15368654
[No Abstract] [Full Text] [Related]
2. Defining COX-2 inhibitors.
Lipsky PE
J Rheumatol Suppl; 2000 Oct; 60():13-6. PubMed ID: 11032097
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular complications of COX2 selective inhibitors cause considerable concern.
Hedner T; Himmelmann A
Blood Press; 2004; 13(5):260-1. PubMed ID: 15545147
[No Abstract] [Full Text] [Related]
4. COX-2 inhibitors.
Crowther CL
Lippincotts Prim Care Pract; 1999; 3(4):394-6. PubMed ID: 10624270
[No Abstract] [Full Text] [Related]
5. [COX-1 and COX-2: functions and pharmacological effects].
Hinz B; Brune K
Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026
[No Abstract] [Full Text] [Related]
6. Future of COX2 inhibitors.
Melnikova I
Nat Rev Drug Discov; 2005 Jun; 4(6):453-4. PubMed ID: 15959950
[No Abstract] [Full Text] [Related]
7. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
Hasdai D; Gottlieb S; Godbourt U; Hod H; Kaluski E
Harefuah; 2002 Oct; 141(10):922-4. PubMed ID: 12420602
[No Abstract] [Full Text] [Related]
8. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296
[No Abstract] [Full Text] [Related]
9. [Progress in the therapy of rheumatism].
Heinzl S
Med Monatsschr Pharm; 1999 Aug; 22(8):225. PubMed ID: 10481432
[No Abstract] [Full Text] [Related]
10. Controversies in COX-2 inhibitor therapy: closing remarks.
Abramson SB; Furst DE; Hochberg MC; Patrono C
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S77-80. PubMed ID: 11695257
[No Abstract] [Full Text] [Related]
11. Cox-2 inhibitors: a new class of medication?
Habershaw TA
Med Health R I; 1999 Sep; 82(9):332-4. PubMed ID: 10517079
[No Abstract] [Full Text] [Related]
12. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].
Oliw E; Wollheim FA
Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877
[No Abstract] [Full Text] [Related]
13. [Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].
He W; Liu CF; Huang CQ
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):184-6. PubMed ID: 12390825
[TBL] [Abstract][Full Text] [Related]
14. Means, responders, and meaning: evaluation of clinical trials in osteoarthritis.
Schnitzer TJ
Arthritis Rheum; 2003 Nov; 48(11):3001-3. PubMed ID: 14613258
[No Abstract] [Full Text] [Related]
15. [COX-2 inhibitors: current status and outlook].
Dannhardt G; Hahn L
Pharm Unserer Zeit; 2000 Mar; 29(2):100-6. PubMed ID: 10763335
[No Abstract] [Full Text] [Related]
16. [Cyclooxygenase 2 inhibitors and lung carcinoma].
Spano JP; Chouahnia K; Morère JF
Bull Cancer; 2004 May; 91 Spec No():S109-12. PubMed ID: 15239338
[TBL] [Abstract][Full Text] [Related]
17. [Role of cyclooxygenase-2 (COG-2) in the etiology of pain].
Nasonova VA
Ter Arkh; 2001; 73(5):56-7. PubMed ID: 11517752
[No Abstract] [Full Text] [Related]
18. Getting a grip on pain. A new drug may revolutionize arthritis care.
Cowley G
Newsweek; 1998 Dec; 132(24):66. PubMed ID: 10338868
[No Abstract] [Full Text] [Related]
19. Treatment of rheumatoid arthritis--we're getting closer.
Kushner I; Ballou SP
J Rheumatol; 1999 Nov; 26(11):2291-3. PubMed ID: 10555878
[No Abstract] [Full Text] [Related]
20. [Arthrosis drugs critically evaluated. Emphasis on cartilage protection].
Wepner U
MMW Fortschr Med; 2002 Mar; 144(13):4-8. PubMed ID: 12001589
[No Abstract] [Full Text] [Related]
[Next] [New Search]